| Home > Publications Database > Circadian Biology and Stroke. > print |
| 001 | 155556 | ||
| 005 | 20230915092328.0 | ||
| 024 | 7 | _ | |a 10.1161/STROKEAHA.120.031742 |2 doi |
| 024 | 7 | _ | |a pmid:33940951 |2 pmid |
| 024 | 7 | _ | |a 0039-2499 |2 ISSN |
| 024 | 7 | _ | |a 1524-4628 |2 ISSN |
| 024 | 7 | _ | |a altmetric:105261701 |2 altmetric |
| 037 | _ | _ | |a DZNE-2021-00734 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Lo, Eng H |b 0 |
| 245 | _ | _ | |a Circadian Biology and Stroke. |
| 260 | _ | _ | |a Philadelphia, Pa. |c 2021 |b Lippincott Williams & Wilkins |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1629793357_7946 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Circadian biology modulates almost all aspects of mammalian physiology, disease, and response to therapies. Emerging data suggest that circadian biology may significantly affect the mechanisms of susceptibility, injury, recovery, and the response to therapy in stroke. In this review/perspective, we survey the accumulating literature and attempt to connect molecular, cellular, and physiological pathways in circadian biology to clinical consequences in stroke. Accounting for the complex and multifactorial effects of circadian rhythm may improve translational opportunities for stroke diagnostics and therapeutics. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |x 0 |f POF IV |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a biomarkers |2 Other |
| 650 | _ | 7 | |a circadian rhythm |2 Other |
| 650 | _ | 7 | |a immune system |2 Other |
| 650 | _ | 7 | |a ischemia |2 Other |
| 650 | _ | 7 | |a neuroprotection |2 Other |
| 650 | _ | 7 | |a sleep |2 Other |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Circadian Rhythm: physiology |2 MeSH |
| 650 | _ | 2 | |a Clinical Trials as Topic: methods |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Inflammation Mediators: physiology |2 MeSH |
| 650 | _ | 2 | |a Neurovascular Coupling: physiology |2 MeSH |
| 650 | _ | 2 | |a Stroke: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Stroke: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Stroke: therapy |2 MeSH |
| 700 | 1 | _ | |a Albers, Gregory W |b 1 |
| 700 | 1 | _ | |a Dichgans, Martin |0 P:(DE-2719)2000030 |b 2 |u dzne |
| 700 | 1 | _ | |a Donnan, Geoffrey |b 3 |
| 700 | 1 | _ | |a Esposito, Elga |b 4 |
| 700 | 1 | _ | |a Foster, Russell |b 5 |
| 700 | 1 | _ | |a Howells, David W |b 6 |
| 700 | 1 | _ | |a Huang, Yi-Ge |b 7 |
| 700 | 1 | _ | |a Ji, Xunming |b 8 |
| 700 | 1 | _ | |a Klerman, Elizabeth B |b 9 |
| 700 | 1 | _ | |a Lee, Sarah |b 10 |
| 700 | 1 | _ | |a Li, Wenlu |b 11 |
| 700 | 1 | _ | |a Liebeskind, David S |b 12 |
| 700 | 1 | _ | |a Lizasoain, Ignacio |b 13 |
| 700 | 1 | _ | |a Mandeville, Emiri T |b 14 |
| 700 | 1 | _ | |a Moro, Maria A |b 15 |
| 700 | 1 | _ | |a Ning, MingMing |b 16 |
| 700 | 1 | _ | |a Ray, David |b 17 |
| 700 | 1 | _ | |a Sakadžić, Sava |b 18 |
| 700 | 1 | _ | |a Saver, Jeffrey L |b 19 |
| 700 | 1 | _ | |a Scheer, Frank A J L |b 20 |
| 700 | 1 | _ | |a Selim, Magdy |b 21 |
| 700 | 1 | _ | |a Tiedt, Steffen |b 22 |
| 700 | 1 | _ | |a Zhang, Fang |b 23 |
| 700 | 1 | _ | |a Buchan, Alastair M |b 24 |
| 773 | _ | _ | |a 10.1161/STROKEAHA.120.031742 |g Vol. 52, no. 6, p. 2180 - 2190 |0 PERI:(DE-600)1467823-8 |n 6 |p 2180 - 2190 |t Stroke |v 52 |y 2021 |x 1524-4628 |
| 909 | C | O | |o oai:pub.dzne.de:155556 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2000030 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
| 915 | _ | _ | |a Allianz-Lizenz |0 StatID:(DE-HGF)0410 |2 StatID |d 2022-11-13 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b STROKE : 2021 |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-13 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-13 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b STROKE : 2021 |d 2022-11-13 |
| 920 | 1 | _ | |0 I:(DE-2719)1111015 |k AG Höglinger 2 |l Coordinator of Clinical Parkinson Research |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1111015 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|